NO981865L - Microorganism Conservation Procedures - Google Patents

Microorganism Conservation Procedures

Info

Publication number
NO981865L
NO981865L NO981865A NO981865A NO981865L NO 981865 L NO981865 L NO 981865L NO 981865 A NO981865 A NO 981865A NO 981865 A NO981865 A NO 981865A NO 981865 L NO981865 L NO 981865L
Authority
NO
Norway
Prior art keywords
microorganism conservation
conservation procedures
procedures
methods
microorganism
Prior art date
Application number
NO981865A
Other languages
Norwegian (no)
Other versions
NO981865D0 (en
Inventor
Roger Randal Charles New
Charles Anthony Hart
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO981865D0 publication Critical patent/NO981865D0/en
Publication of NO981865L publication Critical patent/NO981865L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Fremgangsmåter for konservering av mikroorganismer deriblant virus, slik at infeksiøs evne er bevart, er tilveiebragt, i tillegg til anvendelse av slike fremgangsmåter ved fremstilling av f.eks. vaksiner.Methods for preserving microorganisms including viruses so that infectious capability is preserved are provided, in addition to the use of such methods in the production of e.g. vaccines.

NO981865A 1995-10-25 1998-04-24 Microorganism Conservation Procedures NO981865L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9521806.1A GB9521806D0 (en) 1995-10-25 1995-10-25 Preservation methods
PCT/GB1996/002615 WO1997015331A1 (en) 1995-10-25 1996-10-25 Methods of preserving microorganisms

Publications (2)

Publication Number Publication Date
NO981865D0 NO981865D0 (en) 1998-04-24
NO981865L true NO981865L (en) 1998-06-24

Family

ID=10782855

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981865A NO981865L (en) 1995-10-25 1998-04-24 Microorganism Conservation Procedures

Country Status (12)

Country Link
EP (1) EP0857069A1 (en)
JP (1) JP2000501282A (en)
KR (1) KR19990067029A (en)
CN (1) CN1202829A (en)
AU (1) AU714485B2 (en)
BR (1) BR9610932A (en)
CA (1) CA2235495A1 (en)
GB (1) GB9521806D0 (en)
NO (1) NO981865L (en)
NZ (1) NZ320446A (en)
WO (1) WO1997015331A1 (en)
ZA (1) ZA969015B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645608B2 (en) 2004-08-17 2010-01-12 Pml Microbiologicals, Inc. Microorganism specimen storage, hydrating, transfer and applicator device
KR101819250B1 (en) 2010-03-31 2018-01-16 스타빌리테크 리미티드 Method for preserving alum adjuvants and alum-adjuvanted vaccines
AU2011234264B2 (en) 2010-03-31 2016-02-04 Stabilitech Ltd Excipients for stabilising viral particles, polypeptides or biological material
EP2898890B1 (en) 2010-03-31 2019-08-21 Stabilitech Biopharma Ltd Stabilisation of viral particles
AU2011336410B2 (en) 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Lyophilized viral formulations
CN103347535B (en) 2010-12-02 2015-11-25 昂科利蒂克斯生物科技公司 Liquid virus preparation
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
WO2022020260A1 (en) 2020-07-20 2022-01-27 Stratix Labs Corporation Methods and articles for testing disinfectant and sanitizer efficacy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504429A (en) * 1993-10-12 1997-05-06 チロン ビアジーン，インコーポレイティド How to store recombinant virus
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
GB9424902D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Solubilisation Aids
GB9424901D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Sequestration Agents

Also Published As

Publication number Publication date
ZA969015B (en) 1998-04-28
BR9610932A (en) 1999-12-21
EP0857069A1 (en) 1998-08-12
NZ320446A (en) 1999-05-28
AU714485B2 (en) 2000-01-06
NO981865D0 (en) 1998-04-24
AU7318396A (en) 1997-05-15
KR19990067029A (en) 1999-08-16
GB9521806D0 (en) 1996-01-03
CN1202829A (en) 1998-12-23
CA2235495A1 (en) 1997-05-01
JP2000501282A (en) 2000-02-08
WO1997015331A1 (en) 1997-05-01

Similar Documents

Publication Publication Date Title
HK1019233A1 (en) Animal cells and processes for the replication of influenza viruses
DE2964276D1 (en) Live attenuated human hepatitis-a-virus, method for growing it in cell culture in vitro and composition comprising it
HK1142093A1 (en) Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
ATE322163T1 (en) SUBSTITUTED CYCLOPENTAN DERIVATIVES USEFUL AS NEURAMIDASE INHIBITORS
GB2375113A (en) Virus strains
NO981865L (en) Microorganism Conservation Procedures
DK1296711T3 (en) HPV-E7 for the treatment of human papillomavirus
ID21526A (en) 4-HYDROXYQUINOLIN-3-CARBOXOXIDE AND HYDRAZIDE AS ANTI-VIRUS INGREDIENTS
EE9900481A (en) Small molecules used to treat inflammatory diseases
ES2160706T3 (en) RUBBER ITEMS WITH A PERMEABILITY TO GASES.
NO883594L (en) PROCEDURE FOR THE PREPARATION OF DOUBLE WIRED RNA PREPARATIONS.
ATE255568T1 (en) ISOTHIAZOLECARBONONIC ACID AMIDES
ES2173923T3 (en) PROCEDURE THAT ALLOWS TO INACTIVATE A VIRUS IN THE PRESENCE OF A POLIETER AND AN AGENT.
AR220838A1 (en) PROCEDURE FOR PREPARING AN INFLUENZA VIRUS VACCINE (INFLUENZA); PROCEDURE FOR THE PROPAGATION OF INFLUENZA VIRUSES AND LIQUID CULTIVATION OF CELLS INOCULATED WITH SUCH VIRUSES, OF EXCLUSIVE APPLICATION IN SUCH PROCEDURE FOR PREPARING SUCH VIRUS
CA2411582A1 (en) Method for increasing the antioxidative potential of selenium-containing aqueous solutions
ES2157054T3 (en) PROCEDURE FOR THE STABILIZATION OF PENTAFLUORETAN.
JPS57146587A (en) New physiologically active substance mutastein and preparation thereof
DK1163248T3 (en) 1,5-anhydro-D-fructose substituted with a hydrophobic group for use as an antioxidant and / or emulsifier
AU586520B2 (en) Oligomericdiazaoxaspirodecanes, preparation thereof and use thereof as light stabilizers for polymers
ATE123625T1 (en) PRODUCTION OF ENHANCED BIOCONTROL ACTIVES.
DE59106111D1 (en) TYPE II restriction endonuclease SwaI.
SU1131900A1 (en) Inactivator for microviruses
NO971003L (en) Enteral vaccine against vaginal infections
SU810243A2 (en) Device for disinfecting gas medium
FI893346A (en) ICKE-REVERTERANDE RNA VIRUS.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application